Beijing Strong Biotechnologies Inc Asset Resilience Ratio
Beijing Strong Biotechnologies Inc asset resilience ratio. Beijing Strong Biotechnologies Inc (300406) has an Asset Resilience Ratio of 3.00% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 300406 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Beijing Strong Biotechnologies Inc (2018–2020)
Asset resilience ratio of Beijing Strong Biotechnologies Inc from 2018 to 2020. This chart shows how Beijing Strong Biotechnologies Inc's Asset Resilience Ratio has changed over time. Read Beijing Strong Biotechnologies Inc (300406) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Beijing Strong Biotechnologies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 300406 asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥163.21 Million | 3.0% |
| Total Liquid Assets | CN¥163.21 Million | 3.00% |
Asset Resilience Insights
- Limited Liquidity: Beijing Strong Biotechnologies Inc maintains only 3.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Beijing Strong Biotechnologies Inc Industry Peers by Asset Resilience Ratio
Compare Beijing Strong Biotechnologies Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Diagnósticos da América S.A
SA:DASA3 |
Diagnostics & Research | 10.42% |
|
SMO ClinPlus Co. Ltd.
SHE:301257 |
Diagnostics & Research | 15.78% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
|
RHYTHM Biosciences Ltd
AU:RHY |
Diagnostics & Research | 2.74% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
Beijing Strong Biotechnologies Inc Asset Resilience Ratio by Year (2018–2020)
Beijing Strong Biotechnologies Inc asset resilience ratio by year from 2018 to 2020. The table below shows the annual Asset Resilience Ratio data for Beijing Strong Biotechnologies Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 0.13% | CN¥5.15 Million ≈ $752.88K |
CN¥3.96 Billion ≈ $580.01 Million |
-6.31pp |
| 2018-12-31 | 6.44% | CN¥120.00 Million ≈ $17.56 Million |
CN¥1.86 Billion ≈ $272.87 Million |
-- |
About Beijing Strong Biotechnologies Inc
Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activ… Read more